Skip to main content
    • Aa
    • Aa

Laboratory surveillance of invasive pneumococcal disease in New South Wales, Australia, before and after introduction of 7-valent conjugate vaccine: reduced disease, but not antibiotic resistance rates

  • S. OFTADEH (a1), H. F. GIDDING (a1) (a2) and G. L. GILBERT (a1) (a3)

We compared serotype distributions of Streptococcus pneumoniae isolates from patients aged <5 and ⩾5 years with invasive pneumococcal disease in New South Wales, Australia, and antibiotic susceptibilities of isolates from the <5 years age group only, before (2002–2004) and after (2005–2009) introduction of the 7-valent pneumococcal conjugate vaccine (PCV7). Overall, there were significant decreases in the mean annual number of referred isolates (770 vs. 515) and the proportion belonging to PCV7 serotypes (74% vs. 38%), but non-PCV7 serotypes, particularly 19A, increased (5% vs. 18%). All changes were more marked in the <5 years age group. Susceptibility testing of isolates from the <5 years age group showed variation in resistance between serotypes, but significant overall increases in penicillin non-susceptibility (23% vs. 31%), ceftriaxone resistance (2% vs. 12%) and multidrug resistance (4% vs. 7%) rates; erythromycin resistance fell (32% vs. 25%). Continued surveillance is needed to monitor changes following the introduction of 13-valent PCV in 2012.

Corresponding author
*Author for correspondence: Dr S. Oftadeh, Centre for Infectious Diseases and Microbiology – Public Health (CIDM), Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Darcy Road, Westmead, New South Wales, 2145Australia. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. KL O'Brien , Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374: 893902.

5. JA Bettinger , The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007. Vaccine 2010; 28: 21302136.

6. G Hanquet , Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges. Vaccine 2011; 29: 2856–64.

7. WH Liao , Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan. European Journal of Clinical Microbiology and Infectious Diseases 2010; 29: 489492.

8. MC Pirez , Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay. Pediatric Infectious Disease Journal 2011; 30: 669674.

12. L Dortet , Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology. Diagnostic Microbiology and Infectious Disease 2009; 65: 4957.

13. MR Jacobs , Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. Journal of Clinical Microbiology 2008; 46: 982990.

14. J Linares , Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clinical Microbiology and Infection 2010; 16: 402410.

16. R Dagan , KP Klugman . Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infectious Diseases 2008; 8: 785795.

17. DS Stephens , Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 2005; 365: 855863.

18. A Fenoll , Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccine. Journal of Antimicrobial Chemotherapy 2009; 64: 13381340.

19. HE Hsu , Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. New England Journal of Medicine 2009; 360: 244256.

20. SI Pelton , Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatric Infectious Disease Journal 2007; 26: 468472.

21. R Reinert , Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine 2010; 28: 42494259.

23. CR Yoshioka , Analysis of invasive pneumonia-causing strains of Streptococcus pneumoniae: serotypes and antimicrobial susceptibility. Journal of Pediatric (Rio de Janeiro) 2011; 87: 7075.

24. MA Borg , Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region. Clinical Microbiology and Infection 2009; 15: 232237.

25. KL Nielsen , Characterization and transfer studies of macrolide resistance genes in Streptococcus pneumoniae from Denmark. Scandinavian Journal of Infectious Diseases 2010; 42: 586593.

26. AM Shibl . Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000–2004). Clinical Microbiology and Infection 2008; 14: 876879.

27. E Calbo , Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clinical Microbiology and Infection 2006; 12: 867872.

28. GJ Tyrrell , Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006. Vaccine 2009; 27: 35533560.

31. AR Tunkel , Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases 2004; 39: 12671284.

33. D Lehmann , The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes. Clinical Infectious Diseases 2010; 50: 14771486.

35. SL Kaplan , Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics 2010; 125: 429436.

36. S Maraki , Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine. European Journal of Clinical Microbiology and Infectious Diseases 2010; 29: 14491451.

38. M Imohl , Temporal variations among invasive pneumococcal disease serotypes in children and adults in Germany (1992–2008). International Journal of Microbiology 2010; 2010: 121136.

39. EH Choi , Streptococcus pneumoniae serotype 19A in children, South Korea. Emerging Infectious Diseases 2008; 14: 275281.

40. DR Pillai , Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae . BMC Genomics 2009; 10: 642.

41. X Xu , Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates. Antimicrobial Agents and Chemotherapy 2010; 54: 11521159.

42. WP Hanage , Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. Journal of Infectious Diseases 2007; 195: 347352.

43. BW Beall , Shifting genetic structure of invasive serotype 19A pneumococci in the United States. Journal of Infectious Diseases 2011; 203: 13601368.

44. EJ van Gils , Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. Journal of the American Medical Association 2010; 304: 10991106.

45. HJ Lee , Immune response to 19A serotype after immunization of 19F containing pneumococcal conjugate vaccine in Korean children aged 12–23 months. Korean Journal of Pediatrics 2011; 54: 163168.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *